Multiple factors may limit tTMB and bTMB correlation in our study, including heterogeneity of the cohort comprising multiple tumor types with different genomic alterations; differences in the sensitivity of variant detection between FFPE and plasma; variations in tumor cellularity; temporal and spatial heterogeneity of samples; treatment effects; and so forth. This evidence concerns the gene TMEM200B and neoplasm.